China Universal Asset Management Co., Ltd. Mersana Therapeutics, Inc. Transaction History
China Universal Asset Management Co., Ltd.
- $1.05 Billion
- Q1 2025
A detailed history of China Universal Asset Management Co., Ltd. transactions in Mersana Therapeutics, Inc. stock. As of the latest transaction made, China Universal Asset Management Co., Ltd. holds 24,779 shares of MRSN stock, worth $8,920. This represents 0.0% of its overall portfolio holdings.
Number of Shares
24,779
Previous 26,194
5.4%
Holding current value
$8,920
Previous $37,000
78.38%
% of portfolio
0.0%
Previous 0.0%
Shares
11 transactions
Others Institutions Holding MRSN
# of Institutions
116Shares Held
101MCall Options Held
16.3KPut Options Held
13K-
Nextech Invest Ag12.1MShares$4.34 Million3.22% of portfolio
-
Nextech Invest, Ltd. Zurich, V812.1MShares$4.34 Million0.97% of portfolio
-
Bain Capital Life Sciences Investors, LLC Boston, MA8.66MShares$3.12 Million0.99% of portfolio
-
Black Rock Inc. New York, NY8.38MShares$3.02 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA8.38MShares$3.02 Million0.0% of portfolio
About Mersana Therapeutics, Inc.
- Ticker MRSN
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 97,169,296
- Market Cap $35M
- Description
- Mersana Therapeutics, Inc., a clinical stage biopharmaceutical company, develops antibody drug conjugates (ADC) for cancer patients with unmet need. It develops XMT-1592, a Dolasynthen ADC targeting NaPi2b-expressing tumor cells, which is in phase I clinical trial for the treatment of ovarian cancer and NSCLC adenocarcinoma. The company also dev...